After underperformance of 3-4 years, the pharmaceutical companies are back in the limelight due to the better business prospect and outlook and the earnings trajectory, says Yogesh Mehta, Founder, Yield Maximisers. Yesterday saw the return of Reliance and the IT big boys like TCS, Infosys, […]
